The landscape of dementia prognosis has developed drastically with the advent of subtle biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly tests which can detect Alzheimer's pathology several years prior to symptoms arise. While these technological advancements symbolize remarkable progress in understanding neurodegenerative disorders, they've not diminished https://matti319gqz8.wikilowdown.com/user